Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 20, 2019

DrugPatentWatch Database Preview

Details for Patent: 10,028,925

« Back to Dashboard

Which drugs does patent 10,028,925 protect, and when does it expire?

Patent 10,028,925 protects NAPROXEN SODIUM and is included in one NDA.

This patent has fifteen patent family members in thirteen countries.

Summary for Patent: 10,028,925

Title:	Liquid dosage forms of sodium naproxen
Abstract:	Described herein are oral pharmaceutical compositions comprising liquid dosage forms of sodium naproxen in soft gel capsules. In one embodiment, the pharmaceutical composition comprises sodium naproxen, 0.2-1.0 mole equivalents of a de-ionizing agent per mole of naproxen, polyethylene glycol, and one or more solubilizers such as propylene glycol, polyvinyl pyrrolidone or a combination thereof.
Inventor(s):	Chidambaram; Nachiappan (Sandy, UT), Fatmi; Aqeel A (High Point, NC)
Assignee:	Patheon Softgels, Inc. (High Point, NC)
Application Number:	15/591,512
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,028,925
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 10,028,925
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 10,028,925

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Bionpharma Inc	NAPROXEN SODIUM	naproxen sodium	CAPSULE;ORAL	021920-001	Feb 17, 2006		OTC	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			TEMPORARY RELIEF OF MINOR ACHES AND PAINS	➤ Sign Up
Bionpharma Inc	NAPROXEN SODIUM	naproxen sodium	CAPSULE;ORAL	021920-001	Feb 17, 2006		OTC	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			TEMPORARY REDUCTION OF FEVER	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 10,028,925

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2600023	➤ Sign Up
China	101166520	➤ Sign Up
China	102940887	➤ Sign Up
Cyprus	1118321	➤ Sign Up
Denmark	1863458	➤ Sign Up
European Patent Office	1863458	➤ Sign Up
European Patent Office	3061447	➤ Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.